These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 20335613

  • 1. An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis.
    Sueke H, Kaye SB, Neal T, Hall A, Tuft S, Parry CM.
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4151-5. PubMed ID: 20335613
    [Abstract] [Full Text] [Related]

  • 2. Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis.
    Sueke H, Kaye S, Neal T, Murphy C, Hall A, Whittaker D, Tuft S, Parry C.
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2519-24. PubMed ID: 20019362
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa.
    Chin JN, Jones RN, Sader HS, Savage PB, Rybak MJ.
    J Antimicrob Chemother; 2008 Feb; 61(2):365-70. PubMed ID: 18079128
    [Abstract] [Full Text] [Related]

  • 14. Ticarcillin-tobramycin-rifampin: in vitro synergy of the triplet combination against Pseudomonas aeruginosa.
    Zuravleff JJ, Yu VL, Yee RB.
    J Lab Clin Med; 1983 Jun; 101(6):896-902. PubMed ID: 6406628
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro activity of lauric acid or myristylamine in combination with six antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA).
    Kitahara T, Aoyama Y, Hirakata Y, Kamihira S, Kohno S, Ichikawa N, Nakashima M, Sasaki H, Higuchi S.
    Int J Antimicrob Agents; 2006 Jan; 27(1):51-7. PubMed ID: 16318911
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection.
    Giacometti A, Cirioni O, Kamysz W, Silvestri C, Licci A, Riva A, Łukasiak J, Scalise G.
    Peptides; 2005 Nov; 26(11):2111-6. PubMed ID: 16269345
    [Abstract] [Full Text] [Related]

  • 20. Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli.
    Chin NX, Neu NM, Neu HC.
    Drugs Exp Clin Res; 1986 Nov; 12(12):943-7. PubMed ID: 3569007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.